Related Experiment Video
Updated: Aug 6, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Antisense oligonucleotides: design, implementation and future perspectives in microbiology
Jessica B Kelly1, Glen Brodie1, Merve S Zeden1
1Microbiology, School of Biological and Chemical Sciences, Institute for Health Discovery and Innovation, College of Science and Engineering, University of Galway, Ireland.
Antisense oligonucleotides (ASOs) are a new class of antibacterials, called ASOBiotics, that precisely target bacterial gene expression. These RNA-based therapies offer a promising future for combating bacterial infections.
Area of Science:
- Molecular Biology
- RNA Therapeutics
- Antimicrobial Strategies
Background:
- Traditional antimicrobials target proteins or metabolic pathways.
- RNA-based therapeutics, like mRNA vaccines, have shown clinical success.
- RNA-targeting strategies are now being developed for bacterial infections.
Purpose of the Study:
- To review advances in Antisense Oligonucleotide (ASO) technology for bacterial pathogens.
- To outline design considerations for ASO-based antibacterials (ASOBiotics).
- To discuss challenges and opportunities for developing precision antibacterial therapeutics.
Main Methods:
- Antisense oligonucleotides (ASOs) bind to complementary mRNA sequences.
- ASOs can induce RNase H-mediated mRNA degradation.
- ASOs can also block mRNA translation.
Main Results:
- ASOs are emerging as next-generation antibacterials (ASOBiotics).
- ASOBiotics are designed to silence essential bacterial genes.
- ASO technology offers precision control over bacterial gene expression.
Conclusions:
- ASO technology represents a significant advancement in antimicrobial strategies.
- ASOBiotics hold potential as precision therapeutics against bacterial pathogens.
- Further research is needed to overcome challenges and realize the full potential of ASOBiotics.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Human Virome
